AZD8848 + Placebo to match AZD8848
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Safety,
Conditions
Safety,, Tolerability,, Healthy Subjects
Trial Timeline
Jan 1, 2014 → Feb 1, 2014
NCT ID
NCT01818869About AZD8848 + Placebo to match AZD8848
AZD8848 + Placebo to match AZD8848 is a phase 1 stage product being developed by AstraZeneca for Safety,. The current trial status is completed. This product is registered under clinical trial identifier NCT01818869. Target conditions include Safety,, Tolerability,, Healthy Subjects.
What happened to similar drugs?
3 of 4 similar drugs in Safety, were approved
Approved (3) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01818869 | Phase 1 | Completed |
Competing Products
20 competing products in Safety,